AI assistant
Sending…
PROKIDNEY CORP. — Director's Dealing 2025
Mar 4, 2025
32485_dirs_2025-03-04_12a52fae-2ba1-4c3a-b908-7767d4466d11.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PROKIDNEY CORP. (PROK)
CIK: 0001850270
Period of Report: 2025-03-01
Reporting Person: Weber Darin J. (N/A)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-03-01 | Employee stock option (right to buy) | $1.23 | A | 450000 | Acquired | 2035-03-01 | Class A Ordinary Shares (450000) | Direct |
Footnotes
F1: The option vests in substantially equal monthly installments over the four year period beginning on March 1, 2025.
More from PROKIDNEY CORP.
Regulatory Filings
2026
May 29
Regulatory Filings
2026
May 15
Interim / Quarterly Report
2026
May 15
Annual Report
2026
Apr 17
Regulatory Filings
2026
Mar 18
Regulatory Filings
2026
Mar 18
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3